A Prospective, Randomized Study to Evaluate the Safety and Effectiveness of Steerable Ureteroscopic Renal Evacuation(SURE)Using the CVAC™ Aspiration System Compared to Basketing for the Removal of Renal Calculi Following Laser Lithotripsy
| Registry | NCT04519294 |
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: none, treatment |
| Enrollment | 132 (Actual) |
| Sponsor | Calyxo, Inc. (Industry) |
| Conditions | Kidney Stone, Renal Stone, Urolithiasis |
| Interventions | SURE, Standard Ureteroscopy (Basketing) (Device) |
| Dates | start 2021-06-16, primary completion 2023-01-30, completion 2025-04-30, first posted 2020-08-19, last updated 2026-02-27 |
| Locations | 11 sites in United States |
Related Papers Related Patents Related Grants Related Experts
All trials for Kidney Stone All trials for Renal Stone All trials of SURE All trials of Standard Ureteroscopy (Basketing)
-Summary
The purpose of the study is to compare the effects, good and/or bad, of a treatment for removing kidney stones called the SURE procedure for stone evacuation to the standard treatment using a basket for stone removal.
Expand all sections · Collapse all
+Arms and interventions
| Arm | Type | Interventions | Description |
|---|
| SURE | Active comparator | Device: SURE | |
| Standard Ureteroscopy (Basketing) | Active comparator | Device: Standard Ureteroscopy (Basketing) | |
- SURE (Device): The SURE stone evacuation procedure is a technique intended to more easily and completely remove a kidney stone during a kidney stone treatment. The urologist first uses a laser to break the kidney stone into small pieces. Then with the SURE procedure, the pieces are gently vacuumed out of the kidney instead of retrieving the pieces one-by-one with a basket or leaving them to pass naturally in the urine. Basketing is allowed and might be used with the SURE procedure, if needed to remove some small stones.
- Standard Ureteroscopy (Basketing) (Device): This is a treatment in which the urologist uses a laser to break a kidney stone into small pieces and then uses a tool called a basket to retrieve the pieces one at a time.
+Outcome measures
Primary outcomes
- Stone Free Rate (SFR) - Zero Fragments [30 Days]: The primary efficacy endpoint is the SFR, where stone free status is defined as zero residual fragments at 30 days observed on non-contrast CT (NCCT) (1.25mm slice thickness) by blinded central reviewer(s). The SFR is calculated by determining the number of subjects in each treatment arm with a stone free status of zero fragments and dividing that by the total number of subjects treated in the respective treatment arm.
Secondary outcomes
- Residual Stone Volume (RSV) [30 Days]: A continuous quantitative measure of remaining stone volume following intervention, assessed via post-procedural imaging on NCCT (1.25mm slice thickness) by blinded central reviewer(s).
- Stone Clearance (% Reduction in Stone Volume) [30 Days]: Percent reduction (\[Baseline stone volume- 30-Day stone volume\] / Baseline stone volume) in stone volume following intervention, assessed via post-procedural imaging on NCCT (1.25mm slice thickness) by blinded central reviewer(s).
A positive result indicates a decrease in stone volume removed during the procedure; a negative value indicates an increase in stone volume following the procedure.
+Eligibility
Sex: All, ages: 18 Years to any
Inclusion Criteria:
* Candidate for ureteroscopy with laser lithotripsy;
* Presence of renal stone(s);
* Be willing and able to return for all study-related follow up procedures; and,
* Have been informed of the nature of the study, agreeing to its requirements, and have signed the IRB approved informed consent.
Exclusion Criteria:
* BMI > 45;
* Significant comorbidities;
* Bladder, ureteral or kidney abnormalities;
* Pregnant individuals; or
* Unable to meet the treatment and follow up protocol requirements.
+Posted results
Participant flow
| Milestone | SURE | Standard Ureteroscopy (Basketing) |
|---|
| Started | 46 | 55 |
| Completed | 43 | 50 |
| Not completed | 3 | 5 |
Outcome results
- Stone Free Rate (SFR) - Zero Fragments (Primary), Number, % subjects: SURE 48; Standard Ureteroscopy (Basketing) 49
- Residual Stone Volume (RSV) (Secondary), Mean, mm^3: SURE 14.3 +/- 30.9; Standard Ureteroscopy (Basketing) 70.2 +/- 144.9
- Stone Clearance (% Reduction in Stone Volume) (Secondary), Mean, percent reduction (%): SURE 97.1 +/- 5.4; Standard Ureteroscopy (Basketing) 93.3 +/- 11.7
Adverse events
Time frame: 30 Day
| Arm | Deaths | Serious adverse events | Other adverse events |
|---|
| SURE | 0/67 (0.0%) | 1/67 (1.5%) | 4/67 (6.0%) |
| Standard Ureteroscopy (Basketing) | 0/65 (0.0%) | 2/65 (3.1%) | 5/65 (7.7%) |
Serious adverse events by term
| Term | Organ system | SURE | Standard Ureteroscopy (Basketing) |
|---|
| Sepsis Requiring Hospitalization | Renal and urinary disorders | 1/67 | 2/65 |
Other adverse events by term
| Term | Organ system | SURE | Standard Ureteroscopy (Basketing) |
|---|
| Ureteral Damage | Renal and urinary disorders | 4/67 | 5/65 |
+Locations (11)
| Facility | City | Country | Status |
|---|
| Mayo Clinic | Phoenix, Arizona | United States | |
| Arizona Institute of Urology | Tucson, Arizona | United States | |
| Johns Hopkins | Baltimore, Maryland | United States | |
| New Jersey Urology | Voorhees Township, New Jersey | United States | |
| Albany Medical College | Albany, New York | United States | |
| Duke University | Durham, North Carolina | United States | |
| Prisma Health | Greenville, South Carolina | United States | |
| Urology Austin | Austin, Texas | United States | |
| Dell Medical School, The University of Texas at Austin | Austin, Texas | United States | |
| UT Southwestern Medical Center | Dallas, Texas | United States | |
| Urology of Virginia | Virginia Beach, Virginia | United States | |
+Study documents